← Back to all articles
Weight Loss6 min readJanuary 8, 2026

AOD-9604: The HGH Fragment for Targeted Fat Loss

AOD-9604 is a modified fragment of human growth hormone that targets fat cells specifically. Learn how it works and compares to other fat loss peptides.

AOD-9604 (Advanced Obesity Drug) is a synthetic peptide fragment corresponding to amino acids 177-191 of human growth hormone (HGH). It was specifically engineered to isolate HGH's fat-burning properties without its growth-promoting or blood sugar effects.

How AOD-9604 Works

Unlike full HGH which affects multiple pathways, AOD-9604 is targeted:

  • Stimulates lipolysis (fat breakdown) in adipose tissue
  • Inhibits lipogenesis (fat storage)
  • Does NOT affect blood sugar levels
  • Does NOT promote bone or cartilage growth
  • Does NOT affect IGF-1 levels

Research Findings

  • Clinical trials showed statistically significant weight loss vs. placebo
  • Specifically reduces abdominal fat
  • No significant changes in glucose tolerance
  • FDA has given GRAS (Generally Recognized As Safe) status for oral use

AOD-9604 vs. Other Fat Loss Peptides

FeatureAOD-9604SemaglutideCJC-1295/Ipa
MechanismDirect lipolysisAppetite reductionGH elevation
Appetite EffectNoneStrong reductionMinimal
Blood SugarNo effectImprovesMinimal
Muscle PreservationModerateLowerHigher
AdministrationInjectable/OralInjectable/OralInjectable
CostModerateHighModerate

Stacking AOD-9604

AOD-9604 can be combined with:

  • CJC-1295 + Ipamorelin for GH benefits + targeted fat loss
  • BPC-157 for recovery support during caloric deficit
  • Exercise and dietary optimization

Peptidrop's AI protocol generator generates fat loss protocols that can include AOD-9604 alongside complementary peptides, calculating synergy scores for optimal combinations. See all fat loss peptides or browse our peptide database.

For published research on AOD-9604 and obesity, see PubMed. Clinical findings on this HGH fragment have been published in Obesity Research.

Explore Peptides on Peptidrop

Browse 345+ peptides with AI-powered protocol generation, synergy mapping, and risk simulation.